$VXRT
Vaxart, Inc.

2019 Q1 Form 10-Q Financial Statement

#000143774919009292 Filed on May 09, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $5.407M $1.503M
YoY Change 259.75% -69.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.030M $2.010M
YoY Change 1.0% 11.67%
% of Gross Profit
Research & Development $3.829M $3.408M
YoY Change 12.35% -49.88%
% of Gross Profit
Depreciation & Amortization $130.0K $98.00K
YoY Change 32.65% -2.0%
% of Gross Profit
Operating Expenses $5.855M $5.418M
YoY Change 8.07% -20.32%
Operating Profit -$448.0K -$3.915M
YoY Change -88.56% 3.03%
Interest Expense $107.0K $437.0K
YoY Change -75.51% 337.0%
% of Operating Profit
Other Income/Expense, Net -$641.0K $6.257M
YoY Change -110.24% -1664.25%
Pretax Income -$1.089M $2.342M
YoY Change -146.5% -155.76%
Income Tax $250.0K $28.00K
% Of Pretax Income 1.2%
Net Earnings -$1.339M $2.314M
YoY Change -157.87% -152.59%
Net Earnings / Revenue -24.76% 153.96%
Basic Earnings Per Share -$0.18 $0.54
Diluted Earnings Per Share -$0.18 $0.49
COMMON SHARES
Basic Shares Outstanding 7.301M 3.656M
Diluted Shares Outstanding 7.301M 5.300M

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.400M $17.50M
YoY Change -52.0% -53.46%
Cash & Equivalents $8.400M $17.50M
Short-Term Investments $0.00
Other Short-Term Assets $1.200M $1.100M
YoY Change 9.09% -50.0%
Inventory
Prepaid Expenses
Receivables $5.584M $100.0K
Other Receivables $0.00 $13.20M
Total Short-Term Assets $15.25M $31.90M
YoY Change -52.19% -31.25%
LONG-TERM ASSETS
Property, Plant & Equipment $1.559M $1.000M
YoY Change 55.9% 233.33%
Goodwill
YoY Change
Intangibles $18.63M
YoY Change
Long-Term Investments
YoY Change
Other Assets $104.0K
YoY Change
Total Long-Term Assets $21.06M $24.60M
YoY Change -14.39% 8100.0%
TOTAL ASSETS
Total Short-Term Assets $15.25M $31.90M
Total Long-Term Assets $21.06M $24.60M
Total Assets $36.31M $56.50M
YoY Change -35.74% 20.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $849.0K $1.700M
YoY Change -50.06% -5.56%
Accrued Expenses $1.727M $2.100M
YoY Change -17.76% -30.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $200.0K
YoY Change -100.0%
Long-Term Debt Due $1.700M $1.700M
YoY Change 0.0% 466.67%
Total Short-Term Liabilities $8.550M $7.800M
YoY Change 9.62% 41.82%
LONG-TERM LIABILITIES
Long-Term Debt $1.600M $3.100M
YoY Change -48.39% 3000.0%
Other Long-Term Liabilities $18.00K $14.60M
YoY Change -99.88% 7200.0%
Total Long-Term Liabilities $18.00K $17.70M
YoY Change -99.9% 8750.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.550M $7.800M
Total Long-Term Liabilities $18.00K $17.70M
Total Liabilities $23.73M $25.40M
YoY Change -6.56% 12.89%
SHAREHOLDERS EQUITY
Retained Earnings -$99.36M
YoY Change
Common Stock $111.9M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.58M $31.11M
YoY Change
Total Liabilities & Shareholders Equity $36.31M $56.50M
YoY Change -35.74% 20.99%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$1.339M $2.314M
YoY Change -157.87% -152.59%
Depreciation, Depletion And Amortization $130.0K $98.00K
YoY Change 32.65% -2.0%
Cash From Operating Activities -$4.653M -$10.59M
YoY Change -56.06% -7.91%
INVESTING ACTIVITIES
Capital Expenditures $552.0K $140.0K
YoY Change 294.29%
Acquisitions
YoY Change
Other Investing Activities $0.00 $26.92M
YoY Change -100.0% -283.13%
Cash From Investing Activities -$552.0K $26.78M
YoY Change -102.06% -282.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.500M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.123M -265.0K
YoY Change -901.13% 165.0%
NET CHANGE
Cash From Operating Activities -4.653M -10.59M
Cash From Investing Activities -552.0K 26.78M
Cash From Financing Activities 2.123M -265.0K
Net Change In Cash -3.082M 15.92M
YoY Change -119.35% -160.55%
FREE CASH FLOW
Cash From Operating Activities -$4.653M -$10.59M
Capital Expenditures $552.0K $140.0K
Free Cash Flow -$5.205M -$10.73M
YoY Change -51.49% -6.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
849000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
962000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5584000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1796000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1727000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1518000
CY2019Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
514000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
166000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1700000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1570000
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
111097000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
108513000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
86000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
164000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
560000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
70000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
100000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
164000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
86000
CY2019Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
CY2018Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
18000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
779000
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
413000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
882485
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
538645
CY2019Q1 us-gaap Assets
Assets
36309000
CY2018Q4 us-gaap Assets
Assets
35227000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
15250000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
14645000
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q1 us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
CY2018Q1 us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
6988000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
123000
CY2018Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
72000
CY2019Q1 us-gaap Cash
Cash
8359000
CY2018Q4 us-gaap Cash
Cash
11441000
CY2019Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
CY2018Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
25525000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8400000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8424000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11506000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1571000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17495000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3082000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15924000
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1183454
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1099454
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8341189
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7141189
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8341189
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7141189
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
834000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
714000
CY2019Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Concentration of Credit Risk</div>&nbsp;&#x2013;&nbsp;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. The Company places its cash, cash equivalents and short-term investments at financial institutions that management believes are of high credit quality. The Company is exposed to credit risk in the event of default by the financial institutions holding the cash and cash equivalents to the extent such amounts are in excess of the federally insured limits. The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any losses on its deposits since inception.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The primary focus of the Company&#x2019;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#x2019;s investment policy addresses the level of credit exposure by limiting the concentration in any <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>&nbsp;corporate issuer or sector and establishing a minimum allowable credit rating. The Company generally requires <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> collateral from its customers.</div></div></div></div></div>
CY2018Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
0.22148
CY2018Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-27000
CY2019Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
CY2018Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
35577000
CY2019Q1 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
111000
CY2019Q1 us-gaap Depreciation
Depreciation
130000
CY2018Q1 us-gaap Depreciation
Depreciation
98000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1100000
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
511000
CY2019Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2019Q1 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
658000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
632000
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y215D
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
900000
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
70
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
67
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3546000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2767000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
10166000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1541000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1731000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1732000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1732000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1732000
CY2019Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
22180000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
22180000
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18634000
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5000
CY2018Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2000
CY2018Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Thereafter
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter
CY2018Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within One Year
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear
213000
CY2018Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Three Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears
38000
CY2018Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Two Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears
219000
CY2019Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
CY2018Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-3000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2026000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2010000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1089000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2342000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
250000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-184000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3097000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3788000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1947000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
99000
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5536000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-100000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
469000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
CY2018Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
750924
CY2019Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
CY2018Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
866917
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2018Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
25550
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18634000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19413000
CY2019Q1 us-gaap Interest Expense
InterestExpense
107000
CY2018Q1 us-gaap Interest Expense
InterestExpense
437000
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5000
CY2018Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
72000
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
95000
CY2019Q1 us-gaap Lease Cost
LeaseCost
172000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1083000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
610000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
58000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
415000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
74000
CY2019Q1 us-gaap Liabilities
Liabilities
23733000
CY2018Q4 us-gaap Liabilities
Liabilities
23989000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36309000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35227000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8550000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7475000
CY2019Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
15000
CY2018Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
15000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2123000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-265000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-552000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
26779000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4653000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10590000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1339000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
2314000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1339000
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1975000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1339000
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2581000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-641000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6257000
CY2019Q1 us-gaap Notes Payable
NotesPayable
3200000
CY2019Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
5855000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
5418000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-448000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3915000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
223000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1009000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
697000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
312000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
199000
CY2018Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
146000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
762000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y164D
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1326000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
859000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
470000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
56000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
411000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
192000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
195000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
104000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
157000
CY2019Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
35000
CY2018Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
323000
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
320000
CY2019Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
CY2018Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
21000
CY2019Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
CY2018Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
573000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
552000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
140000
CY2019Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
CY2018Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
339000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3656360
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5299751
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7301189
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1242000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1343000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2500000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2540000
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
CY2018Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
1988000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3259000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2636000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1559000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1066000
CY2019Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
417000
CY2018Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
278000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3829000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3408000
CY2019Q1 us-gaap Restricted Cash
RestrictedCash
50000
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
50000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99355000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97989000
CY2019Q1 us-gaap Revenues
Revenues
5407000
CY2018Q1 us-gaap Revenues
Revenues
1503000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7301189
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
164000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
86000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
200650
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
223389
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
22739
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
24.85
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
865163
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
842424
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.13
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.68
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Other Share Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease
22739
CY2019Q1 us-gaap Short Term Lease Commitment Amount
ShortTermLeaseCommitmentAmount
4000
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000
CY2019Q1 us-gaap Stock Issued1
StockIssued1
CY2018Q1 us-gaap Stock Issued1
StockIssued1
31768000
CY2019Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1200000
CY2018Q1 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
7100000
CY2018Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
31768000
CY2018Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
35577000
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2440000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
12576000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
11238000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-38722000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
31106000
CY2019Q1 us-gaap Sublease Income
SubleaseIncome
54000
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of Estimates</div>&nbsp;&#x2013;&nbsp;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities in the financial statements and accompanying notes. Actual results and outcomes could differ from these estimates and assumptions.</div></div></div></div></div>
CY2019Q1 vxrt Lessee Operating Lease Number Of Leases
LesseeOperatingLeaseNumberOfLeases
5
CY2019Q1 vxrt Lessee Operating Lease Number Of Rightofuse Leases Subleased
LesseeOperatingLeaseNumberOfRightofuseLeasesSubleased
1
CY2019Q1 vxrt Secured Promissory Note Classified Noncurrent
SecuredPromissoryNoteClassifiedNoncurrent
1562000
CY2019Q1 vxrt Accrued Clinical And Manufacturing Expenses Current
AccruedClinicalAndManufacturingExpensesCurrent
24000
CY2018Q4 vxrt Accrued Clinical And Manufacturing Expenses Current
AccruedClinicalAndManufacturingExpensesCurrent
75000
CY2019Q1 vxrt Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2018Q1 vxrt Exchange Ratio Number Of Shares Exchanged Per Share
ExchangeRatioNumberOfSharesExchangedPerShare
0.0201346
CY2019Q1 vxrt Gross Proceeds From Issuance Of Common Stock
GrossProceedsFromIssuanceOfCommonStock
3000000
CY2018Q1 vxrt Impairment Of Property And Equipment
ImpairmentOfPropertyAndEquipment
0
CY2019Q1 vxrt Impairment Of Property And Equipment
ImpairmentOfPropertyAndEquipment
0
CY2019Q1 vxrt Interest Charges Applicable To Convertible Promissory Notes Deemed Dividend
InterestChargesApplicableToConvertiblePromissoryNotesDeemedDividend
CY2018Q1 vxrt Interest Charges Applicable To Convertible Promissory Notes Deemed Dividend
InterestChargesApplicableToConvertiblePromissoryNotesDeemedDividend
295000
CY2019Q1 vxrt Lessee Finance Lease Number Of Leases
LesseeFinanceLeaseNumberOfLeases
0
CY2019Q1 vxrt Lessee Operating Lease Number Leases Exceeding Less Than One Year
LesseeOperatingLeaseNumberLeasesExceedingLessThanOneYear
3
CY2019Q1 vxrt Lessee Operating Lease Number Leases Exceeding One Year
LesseeOperatingLeaseNumberLeasesExceedingOneYear
3
CY2019Q1 vxrt Liability Related To Sale Of Future Royalties Current
LiabilityRelatedToSaleOfFutureRoyaltiesCurrent
3610000
CY2018Q4 vxrt Liability Related To Sale Of Future Royalties Current
LiabilityRelatedToSaleOfFutureRoyaltiesCurrent
3328000
CY2019Q1 vxrt Liability Related To Sale Of Future Royalties Noncurrent
LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent
13291000
CY2018Q4 vxrt Liability Related To Sale Of Future Royalties Noncurrent
LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent
14413000
CY2019Q1 vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
544000
CY2018Q1 vxrt Noncash Interest Expense On Liability
NoncashInterestExpenseOnLiability
298000
CY2019Q1 vxrt Noncash Revenue Related To Sale Of Future Royalties
NoncashRevenueRelatedToSaleOfFutureRoyalties
1384000
CY2018Q1 vxrt Noncash Revenue Related To Sale Of Future Royalties
NoncashRevenueRelatedToSaleOfFutureRoyalties
CY2019Q1 vxrt Reclassification Of Convertible Preferred Stock Warrant Liability To Equity
ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity
CY2018Q1 vxrt Reclassification Of Convertible Preferred Stock Warrant Liability To Equity
ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity
70000
CY2019Q1 vxrt Reserve For Return Of Royalties Current
ReserveForReturnOfRoyaltiesCurrent
339000
CY2018Q4 vxrt Reserve For Return Of Royalties Current
ReserveForReturnOfRoyaltiesCurrent
339000
CY2019Q1 vxrt Secured Promissory Note Classified Current
SecuredPromissoryNoteClassifiedCurrent
1667000
CY2018Q4 vxrt Secured Promissory Note Classified Current
SecuredPromissoryNoteClassifiedCurrent
1667000
CY2018Q4 vxrt Secured Promissory Note Classified Noncurrent
SecuredPromissoryNoteClassifiedNoncurrent
1944000
CY2018Q1 vxrt Stock Issued During Period Value Conversion Of Preferred Stock
StockIssuedDuringPeriodValueConversionOfPreferredStock
CY2018Q4 vxrt Stockholders Equity Adjusted Balance
StockholdersEquityAdjustedBalance
11211000
CY2019Q1 vxrt Warrants Issued
WarrantsIssued
100000
CY2018Q1 vxrt Warrants Issued
WarrantsIssued

Files In Submission

Name View Source Status
0001437749-19-009292-index-headers.html Edgar Link pending
0001437749-19-009292-index.html Edgar Link pending
0001437749-19-009292.txt Edgar Link pending
0001437749-19-009292-xbrl.zip Edgar Link pending
chart.jpg Edgar Link pending
ex_140033.htm Edgar Link pending
ex_140034.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vxrt-20190331.xml Edgar Link completed
vxrt-20190331.xsd Edgar Link pending
vxrt-20190331_cal.xml Edgar Link unprocessable
vxrt-20190331_def.xml Edgar Link unprocessable
vxrt-20190331_lab.xml Edgar Link unprocessable
vxrt-20190331_pre.xml Edgar Link unprocessable
vxrt20190319_10q.htm Edgar Link pending